期刊文献+

影响慢性肝衰竭患者生存时间的独立危险因素及其预测模型 被引量:1

Clinical study of survival time for chronic liver failure
原文传递
导出
摘要 目的探讨影响慢性肝衰竭患者生存时问的独立危险因素,并建立预测模型公式。方法采用回顾性病例分析方法,选择天津市第三中心医院2002年5月2007年5月行人工肝治疗的慢性肝功能衰竭、病历资料完整的患者362例,收集其临床资料,并使用SPSS13.0进行统计学分析,其中定量资料使用t检验和秩和检验,定性资料使用卡方检验,并进一步使用Cox回归分析筛选出对生存时间有影响的独立危险因素。根据Cox回归模型筛选出的独立危险因素建立适合我国慢性肝衰竭的预测模型公式。结果经Cox回归筛选影响生存时间的独立危险因素中有统计学差异的有:Child-Pugh评分、血钠值、是否有胆酶分离、是否有腹水、年龄、酪氨酸、精氨酸。本研究建立的Cox模型(包括Child-Pugh评分、血钠值、是否有胆酶分离、是否有腹水、精氨酸、酪氨酸、年龄)公式为:Cox公式评分=0.31×年龄6.62X合并腹水分数(是为1分,否为2分)+10.16×胆酶分离分数(是为2分,否为1分)+4.65×Child-Pugh分值0.39×血钠值+0.05X酪氨酸值+0.04×精氨酸值。该公式的AuC值为0.782,最佳临界值为27.69。结论Child-Pugh评分、血钠值、是否有胆酶分离、是否有腹水、年龄、酪氨酸、精氨酸是影响生存时间的独立危险因素。本研究建立的Cox模型公式对慢性肝衰竭患者的生存时间有较好的预测性。 Objective To identify independent risk factors influencing the survival time of patients with chronic liver failure and construct a predictive model. Methods Retrospective analysis was applied to clinical data of 362 patients with chronic liver failure treated with artificial liver in Tianjin third centre hospital between May 2002 and May 2007. Data were analyzed with SPSS 13.0 statistic software, t test and rank test were used on quantitative data, chi-square test was used on qualitative data, Cox regression analysis was used to select the independent risk factors influencing the survival time. According to independent risk factors from Cox regression model, a prognostic model was established. Results 1. Independent risk factors (P 〈0.05) influencing the survival time were: Child-Pugh score, bilirubin separation ALT, ascites, arginine, age, tyrosine and serum sodium. 2. By receiver operating characteristic curves (ROC) analysis, the area under ROC (AUR) to predict the outcome of chronic liver failure patients was 0.782, and the cutoff score was 27.69. Conclusions 1. Child-Pugh score, bilirubin separation ALT, ascites, arginine, age, tyrosine and serum sodium are independent risk factors affecting survival time of patients with chronic liver failure. 2. Cox model we constructed can reliably predict the survival time of patients with chronic liver failure.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2009年第2期131-134,共4页 Chinese Journal of Hepatology
基金 天津市卫生局重点攻关项目(07KG9)
关键词 肝功能衰竭 危险因素 生存时间 预测模型 Liver failure Risk factors Survival time Prediction model
  • 相关文献

参考文献8

  • 1Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:830
  • 2Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology, 2001, 33: 464-470.
  • 3Ruf AE, Kremers WK, Chavez LL, et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl, 2005, 11: 336-343.
  • 4Clemmesen JO, Larsen FS, Ejlersen E, et al. Haemodynamic changes after high-volume plasmapheresis in patients with chronic and acute liver failure. Eur J Gastroenterol Hepatol, 1997, 9: 55-60.
  • 5Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology,2006,130:1652-1660.
  • 6Vaquero J, Chung C, Cahill ME, et al. Pathogenesis of hepatic encephalopathy in acute liver failure. Semin Liver Dis, 2003, 23: 259- 269.
  • 7Selcuk H, Uruc I, Temel MA, et al. Factors prognostic of survival in patients awaiting liver transplantation for end-stage liver disease. Dig Dis Sci, 2007, 52: 3217-3223.
  • 8周文红,应豪.慢性重型病毒性肝炎预后因素分析[J].临床肝胆病杂志,2007,23(1):26-27. 被引量:6

二级参考文献14

共引文献833

同被引文献9

  • 1陆卫英,孙莲娜.血清前白蛋白在肝病中的临床意义[J].临床肝胆病杂志,2005,21(1):32-33. 被引量:58
  • 2Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:830
  • 3张戡,谢新生,邹洪兴.血清前白蛋白检测在重型肝炎中的临床应用[J].现代中西医结合杂志,2007,16(4):512-512. 被引量:16
  • 4Wang ZX, Yan LN, Wang WT, et al. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplan- tation for patients with acute-on-chronic hepatitis B liver failure [ J ]. Transplant Proc, 2007,39 (5) : 1501-1504.
  • 5Liu F, Cai LY, Zhong L, et al. Model for end-stage liver disease combined with serum prealbumin to predict the prognosis of patients with decompensated Liver cirrhosis [ J]. J Dig Dis, 2010,11 (6) : 352-357.
  • 6Robert A, Chazouillbres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio [ J ]. Hepatology, 1996,24 (6) : 1392-1394.
  • 7Reichel C, Sudhop T, Braun B, et al. Elevated soluble tumour nec- rosis factor receptor serum concentrations and short-term mortality in liver cirrhosis without acute infections [ J ]. Digestion, 2000,62 ( 1 ) :44-51.
  • 8Merion RM, Wolfe RA, Dykstra DM, et al. Longitudinal assess- ment of mortality risk among candidates for liver transplantation [J]. Liver Transpl, 2003,9( 1 ) :12-18.
  • 9曾东晓,潘林梅,夏春祥.肝病患者血清前白蛋白检测的临床价值分析[J].医学理论与实践,2010,23(11):1314-1315. 被引量:7

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部